Literature DB >> 21060051

Special considerations for pars plana tube-shunt placement in Boston type 1 keratoprosthesis.

Thasarat S Vajaranant1, Michael P Blair, Timothy McMahon, Jacob T Wilensky, Jose de la Cruz.   

Abstract

The Boston type 1 keratoprosthesis has been successfully used in eyes with a poor prognosis for a conventional penetrating keratoplasty. The Boston Type 1 Keratoprosthesis Study Group reported significant postoperative vision improvement with a high rate of graft retention. However, glaucoma has significantly limited visual potential in patients with otherwise successful transplants. Given a crowded anterior chamber, scarring, and/or inability to visualize the anterior segment after the keratoprosthesis implantation, vitrectomy and pars plana tube placement is frequently necessary for intraocular pressure control. In addition, the need for optimal contact lens fitting after surgery necessitates a modified surgical technique for the combined procedure to avoid complications and to achieve optimal visual rehabilitation. We present our technique in a case series of combined vitrectomy and pars plana glaucoma shunt placement for the Boston type 1 keratoprosthesis.

Entities:  

Mesh:

Year:  2010        PMID: 21060051     DOI: 10.1001/archophthalmol.2010.257

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  Analysis of long-term outcomes for combined pars plana vitrectomy (PPV) and glaucoma tube shunt surgery in eyes with advanced glaucoma.

Authors:  A Gandhi; D M Miller; J M Zink; A K Khatana; C D Riemann; M R Petersen; R E Foster; R A Sisk
Journal:  Eye (Lond)       Date:  2013-12-13       Impact factor: 3.775

2.  Innovative approaches to glaucoma management of Boston keratoprosthesis type 1.

Authors:  Thasarat S Vajaranant; Jessica Liu; Jacob Wilensky; M Soledad Cortina; Ahmad A Aref
Journal:  Curr Ophthalmol Rep       Date:  2016-07-26

3.  Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study.

Authors:  Yuying Zhang; Zhancong Ou; Jin Zhou; Jiajie Zhai; Jianjun Gu; Jiaqi Chen
Journal:  Adv Ther       Date:  2020-05-20       Impact factor: 3.845

4.  Combined Corneal Transplant, Glaucoma Drainage Implantation, and Pars Plana Vitrectomy Outcomes in a Pediatric Population.

Authors:  Kelley J Bohm; Alvaro Fernandez-Vega; Luis Acaba-Berrocal; R V Paul Chan; M Soledad Cortina
Journal:  Cornea       Date:  2022-02-05       Impact factor: 3.152

5.  COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.

Authors:  Jennifer I Lim; Lindsay Machen; Andrea Arteaga; Faris I Karas; Robert Hyde; Dingcai Cao; Marcia Niec; Thasarat S Vajaranant; M Soledad Cortina
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

6.  Clinical outcome of a nonvalved Aurolab aqueous drainage implant in posterior segment versus anterior chamber.

Authors:  Devendra Maheshwari; Shylesh Dabke; Sindhushree Rajagopal; Mohideen A Kadar; Rengappa Ramakrishnan
Journal:  Indian J Ophthalmol       Date:  2019-08       Impact factor: 1.848

Review 7.  Challenges of Glaucoma Management in Patients with Type I Boston Keratoprosthesis.

Authors:  Sara M AlHilali; Samar A Al-Swailem
Journal:  Clin Ophthalmol       Date:  2022-02-11

Review 8.  Boston type 1 keratoprosthesis from patient selection through postoperative management: a review for the keratoprosthetic surgeon.

Authors:  Samantha L Williamson; M Soledad Cortina
Journal:  Clin Ophthalmol       Date:  2016-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.